DOD to fund planned manufacturing expansion and to prepare the U.S. for a rapid response to the next pandemic as part of Industrial Base Expansion SAN DIEGO — TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI), and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, today announced […]

Company Moves to Make Total Cell Analysis Solutions Available for Clinical Applications in the European Market FREMONT, Calif. — Clinical flow cytometry laboratories based in Europe can now purchase Cytek cFluor® CE-IVD-certified reagents for their use. Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that a series of single-color cFluor reagents and a […]

First companion diagnostic claim for Illumina’s TruSight™ Oncology Comprehensive (EU) test enables targeted therapy with Bayer’s VITRAKVI® (larotrectinib) for patients with NTRK fusion cancer SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight™ Oncology (TSO) Comprehensive (EU) […]

The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform ‘s-Hertogenbosch, The Netherlands –  ENPICOM, an innovative bioinformatics software company, announced the upcoming expansion of the capabilities of the IGX Platform to unlock seamless analysis of antibody panning data. This major development will allow researchers to analyze antibody display data […]

FOSTER CITY, Calif. — Illumina Ventures, today announced the promotion of Malek Faham, MD, PhD, to Chief Scientist having previously served as both a Venture Partner and Entrepreneur in Residence (EIR). In addition, Charles Lin, PhD, has joined the team as a Principal, and Dave Johnson, PhD, has joined as an Entrepreneur in Residence. “Having […]

CAMBRIDGE, England — CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), today announced the appointment of Dr Paul Brooks as Chief Business Officer. Key to the next stage of the Company’s growth, Paul will be responsible for shaping the company’s commercial business strategy and leading the […]

Proceeds to Enable Commercialization and Scale-Up of Unique RNA Sequencing Technology. Lausanne, Switzerland – Alithea Genomics, a fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced today the closing of a CHF 1 million seed financing round led by the Novalis Biotech Acceleration fund, with participation of Swiss-based private investors. Alithea has developed […]

The FIDA technology enables MIP Discovery to offer Molecularly Imprinted Polymers of unmatched quality. BEDFORD, BEDFORDSHIRE, UNITED KINGDOM — MIP Discovery today announced the adoption of the Fida 1 platform into it’s library of analytical techniques for the characterization of Molecularly Imprinted Polymers. Molecularly Imprinted Polymers (MIPs) are animal free alternatives to antibodies that are completely synthetic and extremely robust. Used […]

GeoMx NextSeq workflow creates a streamlined end-to-end solution for spatial multiomic analysis, reducing user touchpoints, and the need for on-site informatics infrastructure SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a seamless, cloud-based workflow that improves the spatial data analysis experience of […]

– Cooperates with scientists from Lund University to develop improved bladder cancer diagnostics Qlucore – listed on Nasdaq First North – is delighted to announce a new collaboration in the field of precision diagnostics to develop solutions for improved clinical diagnostics of bladder cancer. Bladder cancer is the third classifier model co-operation launched by Qlucore in […]